Semiannual Report — FY2026 H1
What RIBOMIC Inc. reported for the period from 2026-04-01 to 2027-03-31.
Filed 2026-11-13View the original on EDINET
How much it says
52Typical
What moved here
17named for the first time
Its own wording
55terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim accounting period, the company recorded research and development expenses of ¥380 million, an operating loss of ¥578 million and an interim net loss of ¥547 million, while cash and cash equivalents totaled ¥1,896 million. In clinical development, following completion of the Phase 2 trial for achondroplasia (ACH), the company submitted a clinical trial application for Phase 3 (WAKABA) and obtained authorization to conduct the trial. In addition, capital and capital surplus were reduced, and transfers were made to eliminate the accumulated deficit.
Komori's summary of this document, not the document's own words.52Typical
How much this filing saysA weighted roll-up of 9 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 34 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
93
Very detailed
61
Detailed
27
Almost nothing
75
Very detailed
0
Almost nothing
27
Almost nothing
78
Very detailed
55
Typical
50
Typical
R&D spend4億円Money spent making new things.
Cash left over-8億円Cash from the business, less what went into equipment.
Spent on equipment5百万円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.